entity,start_date,end_date,context,AARSRAPPORT_html,AARSRAPPORT_pdf,AARSRAPPORT_xml,AddressOfAuditorCountry,AddressOfAuditorCountryIdentificationCode,AddressOfAuditorDistrictName,AddressOfAuditorPostCodeIdentifier,AddressOfAuditorStreetBuildingIdentifier,AddressOfAuditorStreetName,AddressOfReportingEntityCountry,AddressOfReportingEntityCountryIdentificationCode,AddressOfReportingEntityDistrictName,AddressOfReportingEntityPostCodeIdentifier,AddressOfReportingEntityStreetBuildingIdentifier,AddressOfReportingEntityStreetName,AddressOfSubmittingEnterprisePostcodeAndTown,AddressOfSubmittingEnterpriseStreetAndNumber,AddresseeOfAuditorsReportOnAuditedFinancialStatements,AdjustmentsForCurrentTaxRelatingToTaxRateChangesOrImpositionOfNewTaxes,AdjustmentsForDeferredTax,AverageNumberOfEmployees,ClassOfReportingEntity,ConfirmationThatAnnualReportIsPresentedInAccordanceWithRequirementsProvidedForByLegislationAnyStandardsAndRequirementsProvidedByArticlesOfAssociationOrByAgreement,ConfirmationThatFinancialStatementGivesTrueAndFairViewOfAssetsLiabilitiesEquityFinancialPositionAndResults,CurrentTaxExpense,DateOfApprovalOfReport,DateOfFoundationOfReportingEntity,DateOfGeneralMeeting,DescriptionOfMethodsOfDividends,DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfEmployeeBenefitExpense,DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfFinanceIncomeAndExpenses,DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfLiabilitiesOtherThanProvisions,DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfOtherOperatingIncomeAndExpenses,DescriptionOfMethodsOfRecognitionAndMeasurementBasisOfReceivables,EmployeeBenefitsExpense,ExchangeRateLoss,GrossProfitLoss,HomepageOfReportingEntity,IdentificationNumberCvrOfAuditFirm,IdentificationNumberCvrOfReportingEntity,IdentificationNumberCvrOfSubmittingEnterprise,IdentificationOfApprovedAnnualReport,IdentificationOfAuditedFinancialStatements,InformationOnTypeOfSubmittedReport,ManagementsStatementAboutManagementsReview,NameAndSurnameOfChairmanOfGeneralMeeting,NameAndSurnameOfMemberOfExecutiveBoard,NameOfReportingEntity,NameOfSubmittingEnterprise,OpinionOnAuditedFinancialStatements,OtherFinanceExpenses,OtherInterestExpenses,PostemploymentBenefitExpense,ProfitLoss,ProfitLossFromOrdinaryActivitiesBeforeTax,ProfitLossFromOrdinaryOperatingActivities,RegisteredOfficeOfReportingEntity,ReportingPeriodEndDate,ReportingPeriodStartDate,SignatureOfAuditorsPlace,SocialSecurityContributions,StatementOfExecutiveAndSupervisoryBoardsResponsibilityForFinancialStatements,StatementOnManagementsReviewAuditorsReportOnAuditedFinancialStatements,SupplementaryInformationOnOtherMatters,TaxExpense,TelephoneNumberOfAuditor,TelephoneNumberOfReportingEntity,TypeOfAuditorAssistance,WagesAndSalaries,_id,_index,_score,cvrNummer,indlaesningsId,indlaesningsTidspunkt,offentliggoerelsesTidspunkt,offentliggoerelsestype,omgoerelse,regNummer,regnskabsperiode_slutDato,regnskabsperiode_startDato,sagsNummer,sidstOpdateret,DeferredTaxLiability,Assets,ContributedCapital,CurrentAssets,CurrentDeferredTaxAssets,DeferredIncomeAssets,Equity,Inventories,LiabilitiesAndEquity,LiabilitiesOtherThanProvisions,ManufacturedGoodsAndGoodsForResale,OtherShorttermPayables,RetainedEarnings,ShorttermLiabilitiesOtherThanProvisions,ShorttermPayablesToGroupEnterprises,ShorttermPrepaymentsReceivedFromCustomers,ShorttermReceivables,ShorttermReceivablesFromGroupEnterprises,ShorttermTaxPayables,ShorttermTradePayables,ShorttermTradeReceivables,NameAndSurnameOfAuditor,NameOfAuditFirm,NameAndSurnameOfMemberOfSupervisoryBoard
73131510,2013-01-01,2013-12-31,c58,,http://regnskaber.virk.dk/01513137/ZG9rdW1lbnRsYWdlcjovLzAzL2ZkLzBlLzhiLzljLzA1YWEtNDVlZi05OWJjLTQxNDg1OTVhNGZiNw.pdf,http://regnskaber.virk.dk/01513137/ZG9rdW1lbnRsYWdlcjovLzAzLzQ4Lzk5LzI4L2I4LzkyZjctNDA2MC04ZTE4LWRjZTk5ZjZhN2YyNQ.xml,Danmark,DK,Copenhagen,2100.0,38.0,Amerika Plads,Danmark,DK,Hellerup,DK-2900,102 E,Strandvejen,2100 KÃ¸benhavn Ã,Amerika Plads 38,To the Shareholder of Merck Life Science A/S (former Millipore A/S),0.0,13000.0,7.0,Regnskabsklasse B,The annual report has been prepared in accordance with the Danish Financial Statements Act.,"It is our opinion that the financial statements give a true and fair view of the Company's assets, liabilities and financial position at 31 December 2014 and of the result of the Company's operations  for the year 1 January - 31 December 2014.",1606000.0,2015-05-29,1982-12-31,2015-05-29,Proposed dividends are recognised as a liability at the date when they are adopted at the annual general meeting (declaration date). The expected dividend payment for the year is disclosed as a separate item under equity.,Staff expenses comprise wages and salaries as well as payroll expenses.,"Interest income and interest expenses comprise interest income and expense, gains and losses on payables and transactions denominated in foreign currencies, amortisation of financial assets and liabilities as well as surcharges and refunds under the on-account tax scheme. etc.",Financial liabilities are measured at amortised cost. Other liabilities are measured at net realisable value.,"Other external expenses comprise expenses incurred for travelling, administration and other external expenses.",Receivables are measured at amortised cost. Provision is made for anticipated losses at net realisable value.,5675000.0,7000.0,12295000.0,www.millipore.com,25578198.0,73131510.0,25578198.0,The Executive and the Board of Directors have today discussed and approved the annual report of Merck Life Science A/S (former Millipore A/S) for the financial year 1 January - 31 December 2014.,"We have audited the financial statements of Merck Life Science A/S (former Millipore A/S) for the financial year 1 January - 31 December 2014. The financial statements comprise accounting policies, income statement, balance sheet and notes. The financial statements are prepared in accordance with the Danish Financial Statements Act.",Ãrsrapport,"In our opinion, the Management's review includes a fair review of the development in the Company's operations and financial conditions, the result for the year and the financial position.",Susanne Krogh,Hans Christopher Elers Koch,Merck Life Science A/S (former Millipore A/S),KPMG,"In our opinion, the financial statements give a true and fair view of the Company's financial position at 31 December 2014 and of the results of the Company's operations for the financial year 1 January - 31 December 2014 in accordance with the Danish Financial Statements Act.",126000.0,119000.0,434000.0,4875000.0,6494000.0,6620000.0,Copenhagen,2014-12-31,2014-01-01,Copenhagen,22000.0,"Management is responsible for the preparation and presentation of financial statements that give a true and fair view in accordance with the Danish Financial Statements Act and for such internal control that Management determines is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.","Pursuant to the Danish Financial Statements Act, we have read the Management's review. We have not performed any further procedures in addition to the audit of the financial statements. On this basis, it is our opinion that the information provided in the Management's review is consistent with the financial statements.","Without modifying our opinion, we draw attention to the fact that the Company does not comply with the requirements of the Danish Bookkeeping Act on preservation of accounting records.",1619000.0,70707760.0,+45 70 10 56 45,RevisionspÃ¥tegning,5219000.0,urn:ofk:oid:5447722,indberetninger-20180424,2.5118535,73131510.0,,2018-03-30T13:09:18.582Z,2015-06-04T10:08:14.884Z,regnskab,0.0,,2014-12-31,2014-01-01,X15-AD-15-AL,2015-06-04T10:08:15.276Z,,,,,,,,,,,,,,,,,,,,,,,,
73131510,2013-01-01,2013-12-31,c73,,http://regnskaber.virk.dk/01513137/ZG9rdW1lbnRsYWdlcjovLzAzL2ZkLzBlLzhiLzljLzA1YWEtNDVlZi05OWJjLTQxNDg1OTVhNGZiNw.pdf,http://regnskaber.virk.dk/01513137/ZG9rdW1lbnRsYWdlcjovLzAzLzQ4Lzk5LzI4L2I4LzkyZjctNDA2MC04ZTE4LWRjZTk5ZjZhN2YyNQ.xml,Danmark,DK,Copenhagen,2100.0,38.0,Amerika Plads,Danmark,DK,Hellerup,DK-2900,102 E,Strandvejen,2100 KÃ¸benhavn Ã,Amerika Plads 38,To the Shareholder of Merck Life Science A/S (former Millipore A/S),,,,Regnskabsklasse B,The annual report has been prepared in accordance with the Danish Financial Statements Act.,"It is our opinion that the financial statements give a true and fair view of the Company's assets, liabilities and financial position at 31 December 2014 and of the result of the Company's operations  for the year 1 January - 31 December 2014.",,2015-05-29,1982-12-31,2015-05-29,Proposed dividends are recognised as a liability at the date when they are adopted at the annual general meeting (declaration date). The expected dividend payment for the year is disclosed as a separate item under equity.,Staff expenses comprise wages and salaries as well as payroll expenses.,"Interest income and interest expenses comprise interest income and expense, gains and losses on payables and transactions denominated in foreign currencies, amortisation of financial assets and liabilities as well as surcharges and refunds under the on-account tax scheme. etc.",Financial liabilities are measured at amortised cost. Other liabilities are measured at net realisable value.,"Other external expenses comprise expenses incurred for travelling, administration and other external expenses.",Receivables are measured at amortised cost. Provision is made for anticipated losses at net realisable value.,,,,www.millipore.com,25578198.0,73131510.0,25578198.0,The Executive and the Board of Directors have today discussed and approved the annual report of Merck Life Science A/S (former Millipore A/S) for the financial year 1 January - 31 December 2014.,"We have audited the financial statements of Merck Life Science A/S (former Millipore A/S) for the financial year 1 January - 31 December 2014. The financial statements comprise accounting policies, income statement, balance sheet and notes. The financial statements are prepared in accordance with the Danish Financial Statements Act.",Ãrsrapport,"In our opinion, the Management's review includes a fair review of the development in the Company's operations and financial conditions, the result for the year and the financial position.",Susanne Krogh,Hans Christopher Elers Koch,Merck Life Science A/S (former Millipore A/S),KPMG,"In our opinion, the financial statements give a true and fair view of the Company's financial position at 31 December 2014 and of the results of the Company's operations for the financial year 1 January - 31 December 2014 in accordance with the Danish Financial Statements Act.",,,,4875000.0,,,Copenhagen,2014-12-31,2014-01-01,Copenhagen,,"Management is responsible for the preparation and presentation of financial statements that give a true and fair view in accordance with the Danish Financial Statements Act and for such internal control that Management determines is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.","Pursuant to the Danish Financial Statements Act, we have read the Management's review. We have not performed any further procedures in addition to the audit of the financial statements. On this basis, it is our opinion that the information provided in the Management's review is consistent with the financial statements.","Without modifying our opinion, we draw attention to the fact that the Company does not comply with the requirements of the Danish Bookkeeping Act on preservation of accounting records.",,70707760.0,+45 70 10 56 45,RevisionspÃ¥tegning,,urn:ofk:oid:5447722,indberetninger-20180424,2.5118535,73131510.0,,2018-03-30T13:09:18.582Z,2015-06-04T10:08:14.884Z,regnskab,0.0,,2014-12-31,2014-01-01,X15-AD-15-AL,2015-06-04T10:08:15.276Z,,,,,,,,,,,,,,,,,,,,,,,,
73131510,2013-12-31,2013-12-31,c424,,http://regnskaber.virk.dk/01513137/ZG9rdW1lbnRsYWdlcjovLzAzL2ZkLzBlLzhiLzljLzA1YWEtNDVlZi05OWJjLTQxNDg1OTVhNGZiNw.pdf,http://regnskaber.virk.dk/01513137/ZG9rdW1lbnRsYWdlcjovLzAzLzQ4Lzk5LzI4L2I4LzkyZjctNDA2MC04ZTE4LWRjZTk5ZjZhN2YyNQ.xml,Danmark,DK,Copenhagen,2100.0,38.0,Amerika Plads,Danmark,DK,Hellerup,DK-2900,102 E,Strandvejen,2100 KÃ¸benhavn Ã,Amerika Plads 38,To the Shareholder of Merck Life Science A/S (former Millipore A/S),,,,Regnskabsklasse B,The annual report has been prepared in accordance with the Danish Financial Statements Act.,"It is our opinion that the financial statements give a true and fair view of the Company's assets, liabilities and financial position at 31 December 2014 and of the result of the Company's operations  for the year 1 January - 31 December 2014.",,2015-05-29,1982-12-31,2015-05-29,Proposed dividends are recognised as a liability at the date when they are adopted at the annual general meeting (declaration date). The expected dividend payment for the year is disclosed as a separate item under equity.,Staff expenses comprise wages and salaries as well as payroll expenses.,"Interest income and interest expenses comprise interest income and expense, gains and losses on payables and transactions denominated in foreign currencies, amortisation of financial assets and liabilities as well as surcharges and refunds under the on-account tax scheme. etc.",Financial liabilities are measured at amortised cost. Other liabilities are measured at net realisable value.,"Other external expenses comprise expenses incurred for travelling, administration and other external expenses.",Receivables are measured at amortised cost. Provision is made for anticipated losses at net realisable value.,,,,www.millipore.com,25578198.0,73131510.0,25578198.0,The Executive and the Board of Directors have today discussed and approved the annual report of Merck Life Science A/S (former Millipore A/S) for the financial year 1 January - 31 December 2014.,"We have audited the financial statements of Merck Life Science A/S (former Millipore A/S) for the financial year 1 January - 31 December 2014. The financial statements comprise accounting policies, income statement, balance sheet and notes. The financial statements are prepared in accordance with the Danish Financial Statements Act.",Ãrsrapport,"In our opinion, the Management's review includes a fair review of the development in the Company's operations and financial conditions, the result for the year and the financial position.",Susanne Krogh,Hans Christopher Elers Koch,Merck Life Science A/S (former Millipore A/S),KPMG,"In our opinion, the financial statements give a true and fair view of the Company's financial position at 31 December 2014 and of the results of the Company's operations for the financial year 1 January - 31 December 2014 in accordance with the Danish Financial Statements Act.",,,,,,,Copenhagen,2014-12-31,2014-01-01,Copenhagen,,"Management is responsible for the preparation and presentation of financial statements that give a true and fair view in accordance with the Danish Financial Statements Act and for such internal control that Management determines is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.","Pursuant to the Danish Financial Statements Act, we have read the Management's review. We have not performed any further procedures in addition to the audit of the financial statements. On this basis, it is our opinion that the information provided in the Management's review is consistent with the financial statements.","Without modifying our opinion, we draw attention to the fact that the Company does not comply with the requirements of the Danish Bookkeeping Act on preservation of accounting records.",,70707760.0,+45 70 10 56 45,RevisionspÃ¥tegning,,urn:ofk:oid:5447722,indberetninger-20180424,2.5118535,73131510.0,,2018-03-30T13:09:18.582Z,2015-06-04T10:08:14.884Z,regnskab,0.0,,2014-12-31,2014-01-01,X15-AD-15-AL,2015-06-04T10:08:15.276Z,25000.0,,,,,,,,,,,,,,,,,,,,,,,
73131510,2013-12-31,2013-12-31,c426,,http://regnskaber.virk.dk/01513137/ZG9rdW1lbnRsYWdlcjovLzAzL2ZkLzBlLzhiLzljLzA1YWEtNDVlZi05OWJjLTQxNDg1OTVhNGZiNw.pdf,http://regnskaber.virk.dk/01513137/ZG9rdW1lbnRsYWdlcjovLzAzLzQ4Lzk5LzI4L2I4LzkyZjctNDA2MC04ZTE4LWRjZTk5ZjZhN2YyNQ.xml,Danmark,DK,Copenhagen,2100.0,38.0,Amerika Plads,Danmark,DK,Hellerup,DK-2900,102 E,Strandvejen,2100 KÃ¸benhavn Ã,Amerika Plads 38,To the Shareholder of Merck Life Science A/S (former Millipore A/S),,,,Regnskabsklasse B,The annual report has been prepared in accordance with the Danish Financial Statements Act.,"It is our opinion that the financial statements give a true and fair view of the Company's assets, liabilities and financial position at 31 December 2014 and of the result of the Company's operations  for the year 1 January - 31 December 2014.",,2015-05-29,1982-12-31,2015-05-29,Proposed dividends are recognised as a liability at the date when they are adopted at the annual general meeting (declaration date). The expected dividend payment for the year is disclosed as a separate item under equity.,Staff expenses comprise wages and salaries as well as payroll expenses.,"Interest income and interest expenses comprise interest income and expense, gains and losses on payables and transactions denominated in foreign currencies, amortisation of financial assets and liabilities as well as surcharges and refunds under the on-account tax scheme. etc.",Financial liabilities are measured at amortised cost. Other liabilities are measured at net realisable value.,"Other external expenses comprise expenses incurred for travelling, administration and other external expenses.",Receivables are measured at amortised cost. Provision is made for anticipated losses at net realisable value.,,,,www.millipore.com,25578198.0,73131510.0,25578198.0,The Executive and the Board of Directors have today discussed and approved the annual report of Merck Life Science A/S (former Millipore A/S) for the financial year 1 January - 31 December 2014.,"We have audited the financial statements of Merck Life Science A/S (former Millipore A/S) for the financial year 1 January - 31 December 2014. The financial statements comprise accounting policies, income statement, balance sheet and notes. The financial statements are prepared in accordance with the Danish Financial Statements Act.",Ãrsrapport,"In our opinion, the Management's review includes a fair review of the development in the Company's operations and financial conditions, the result for the year and the financial position.",Susanne Krogh,Hans Christopher Elers Koch,Merck Life Science A/S (former Millipore A/S),KPMG,"In our opinion, the financial statements give a true and fair view of the Company's financial position at 31 December 2014 and of the results of the Company's operations for the financial year 1 January - 31 December 2014 in accordance with the Danish Financial Statements Act.",,,,,,,Copenhagen,2014-12-31,2014-01-01,Copenhagen,,"Management is responsible for the preparation and presentation of financial statements that give a true and fair view in accordance with the Danish Financial Statements Act and for such internal control that Management determines is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.","Pursuant to the Danish Financial Statements Act, we have read the Management's review. We have not performed any further procedures in addition to the audit of the financial statements. On this basis, it is our opinion that the information provided in the Management's review is consistent with the financial statements.","Without modifying our opinion, we draw attention to the fact that the Company does not comply with the requirements of the Danish Bookkeeping Act on preservation of accounting records.",,70707760.0,+45 70 10 56 45,RevisionspÃ¥tegning,,urn:ofk:oid:5447722,indberetninger-20180424,2.5118535,73131510.0,,2018-03-30T13:09:18.582Z,2015-06-04T10:08:14.884Z,regnskab,0.0,,2014-12-31,2014-01-01,X15-AD-15-AL,2015-06-04T10:08:15.276Z,-13000.0,,,,,,,,,,,,,,,,,,,,,,,
73131510,2013-12-31,2013-12-31,c74,,http://regnskaber.virk.dk/01513137/ZG9rdW1lbnRsYWdlcjovLzAzL2ZkLzBlLzhiLzljLzA1YWEtNDVlZi05OWJjLTQxNDg1OTVhNGZiNw.pdf,http://regnskaber.virk.dk/01513137/ZG9rdW1lbnRsYWdlcjovLzAzLzQ4Lzk5LzI4L2I4LzkyZjctNDA2MC04ZTE4LWRjZTk5ZjZhN2YyNQ.xml,Danmark,DK,Copenhagen,2100.0,38.0,Amerika Plads,Danmark,DK,Hellerup,DK-2900,102 E,Strandvejen,2100 KÃ¸benhavn Ã,Amerika Plads 38,To the Shareholder of Merck Life Science A/S (former Millipore A/S),,,,Regnskabsklasse B,The annual report has been prepared in accordance with the Danish Financial Statements Act.,"It is our opinion that the financial statements give a true and fair view of the Company's assets, liabilities and financial position at 31 December 2014 and of the result of the Company's operations  for the year 1 January - 31 December 2014.",,2015-05-29,1982-12-31,2015-05-29,Proposed dividends are recognised as a liability at the date when they are adopted at the annual general meeting (declaration date). The expected dividend payment for the year is disclosed as a separate item under equity.,Staff expenses comprise wages and salaries as well as payroll expenses.,"Interest income and interest expenses comprise interest income and expense, gains and losses on payables and transactions denominated in foreign currencies, amortisation of financial assets and liabilities as well as surcharges and refunds under the on-account tax scheme. etc.",Financial liabilities are measured at amortised cost. Other liabilities are measured at net realisable value.,"Other external expenses comprise expenses incurred for travelling, administration and other external expenses.",Receivables are measured at amortised cost. Provision is made for anticipated losses at net realisable value.,,,,www.millipore.com,25578198.0,73131510.0,25578198.0,The Executive and the Board of Directors have today discussed and approved the annual report of Merck Life Science A/S (former Millipore A/S) for the financial year 1 January - 31 December 2014.,"We have audited the financial statements of Merck Life Science A/S (former Millipore A/S) for the financial year 1 January - 31 December 2014. The financial statements comprise accounting policies, income statement, balance sheet and notes. The financial statements are prepared in accordance with the Danish Financial Statements Act.",Ãrsrapport,"In our opinion, the Management's review includes a fair review of the development in the Company's operations and financial conditions, the result for the year and the financial position.",Susanne Krogh,Hans Christopher Elers Koch,Merck Life Science A/S (former Millipore A/S),KPMG,"In our opinion, the financial statements give a true and fair view of the Company's financial position at 31 December 2014 and of the results of the Company's operations for the financial year 1 January - 31 December 2014 in accordance with the Danish Financial Statements Act.",,,,,,,Copenhagen,2014-12-31,2014-01-01,Copenhagen,,"Management is responsible for the preparation and presentation of financial statements that give a true and fair view in accordance with the Danish Financial Statements Act and for such internal control that Management determines is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.","Pursuant to the Danish Financial Statements Act, we have read the Management's review. We have not performed any further procedures in addition to the audit of the financial statements. On this basis, it is our opinion that the information provided in the Management's review is consistent with the financial statements.","Without modifying our opinion, we draw attention to the fact that the Company does not comply with the requirements of the Danish Bookkeeping Act on preservation of accounting records.",,70707760.0,+45 70 10 56 45,RevisionspÃ¥tegning,,urn:ofk:oid:5447722,indberetninger-20180424,2.5118535,73131510.0,,2018-03-30T13:09:18.582Z,2015-06-04T10:08:14.884Z,regnskab,0.0,,2014-12-31,2014-01-01,X15-AD-15-AL,2015-06-04T10:08:15.276Z,,21592000.0,2000000.0,21592000.0,12000.0,32000.0,14347000.0,1698000.0,21592000.0,7245000.0,1698000.0,4300000.0,12347000.0,7245000.0,0.0,1499000.0,19894000.0,3674000.0,1111000.0,335000.0,16176000.0,,,
73131510,2014-01-01,2014-01-01,c113,,http://regnskaber.virk.dk/01513137/ZG9rdW1lbnRsYWdlcjovLzAzL2ZkLzBlLzhiLzljLzA1YWEtNDVlZi05OWJjLTQxNDg1OTVhNGZiNw.pdf,http://regnskaber.virk.dk/01513137/ZG9rdW1lbnRsYWdlcjovLzAzLzQ4Lzk5LzI4L2I4LzkyZjctNDA2MC04ZTE4LWRjZTk5ZjZhN2YyNQ.xml,Danmark,DK,Copenhagen,2100.0,38.0,Amerika Plads,Danmark,DK,Hellerup,DK-2900,102 E,Strandvejen,2100 KÃ¸benhavn Ã,Amerika Plads 38,To the Shareholder of Merck Life Science A/S (former Millipore A/S),,,,Regnskabsklasse B,The annual report has been prepared in accordance with the Danish Financial Statements Act.,"It is our opinion that the financial statements give a true and fair view of the Company's assets, liabilities and financial position at 31 December 2014 and of the result of the Company's operations  for the year 1 January - 31 December 2014.",,2015-05-29,1982-12-31,2015-05-29,Proposed dividends are recognised as a liability at the date when they are adopted at the annual general meeting (declaration date). The expected dividend payment for the year is disclosed as a separate item under equity.,Staff expenses comprise wages and salaries as well as payroll expenses.,"Interest income and interest expenses comprise interest income and expense, gains and losses on payables and transactions denominated in foreign currencies, amortisation of financial assets and liabilities as well as surcharges and refunds under the on-account tax scheme. etc.",Financial liabilities are measured at amortised cost. Other liabilities are measured at net realisable value.,"Other external expenses comprise expenses incurred for travelling, administration and other external expenses.",Receivables are measured at amortised cost. Provision is made for anticipated losses at net realisable value.,,,,www.millipore.com,25578198.0,73131510.0,25578198.0,The Executive and the Board of Directors have today discussed and approved the annual report of Merck Life Science A/S (former Millipore A/S) for the financial year 1 January - 31 December 2014.,"We have audited the financial statements of Merck Life Science A/S (former Millipore A/S) for the financial year 1 January - 31 December 2014. The financial statements comprise accounting policies, income statement, balance sheet and notes. The financial statements are prepared in accordance with the Danish Financial Statements Act.",Ãrsrapport,"In our opinion, the Management's review includes a fair review of the development in the Company's operations and financial conditions, the result for the year and the financial position.",Susanne Krogh,Hans Christopher Elers Koch,Merck Life Science A/S (former Millipore A/S),KPMG,"In our opinion, the financial statements give a true and fair view of the Company's financial position at 31 December 2014 and of the results of the Company's operations for the financial year 1 January - 31 December 2014 in accordance with the Danish Financial Statements Act.",,,,,,,Copenhagen,2014-12-31,2014-01-01,Copenhagen,,"Management is responsible for the preparation and presentation of financial statements that give a true and fair view in accordance with the Danish Financial Statements Act and for such internal control that Management determines is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.","Pursuant to the Danish Financial Statements Act, we have read the Management's review. We have not performed any further procedures in addition to the audit of the financial statements. On this basis, it is our opinion that the information provided in the Management's review is consistent with the financial statements.","Without modifying our opinion, we draw attention to the fact that the Company does not comply with the requirements of the Danish Bookkeeping Act on preservation of accounting records.",,70707760.0,+45 70 10 56 45,RevisionspÃ¥tegning,,urn:ofk:oid:5447722,indberetninger-20180424,2.5118535,73131510.0,,2018-03-30T13:09:18.582Z,2015-06-04T10:08:14.884Z,regnskab,0.0,,2014-12-31,2014-01-01,X15-AD-15-AL,2015-06-04T10:08:15.276Z,,,,,,,2000000.0,,,,,,,,,,,,,,,,,
73131510,2014-01-01,2014-01-01,c131,,http://regnskaber.virk.dk/01513137/ZG9rdW1lbnRsYWdlcjovLzAzL2ZkLzBlLzhiLzljLzA1YWEtNDVlZi05OWJjLTQxNDg1OTVhNGZiNw.pdf,http://regnskaber.virk.dk/01513137/ZG9rdW1lbnRsYWdlcjovLzAzLzQ4Lzk5LzI4L2I4LzkyZjctNDA2MC04ZTE4LWRjZTk5ZjZhN2YyNQ.xml,Danmark,DK,Copenhagen,2100.0,38.0,Amerika Plads,Danmark,DK,Hellerup,DK-2900,102 E,Strandvejen,2100 KÃ¸benhavn Ã,Amerika Plads 38,To the Shareholder of Merck Life Science A/S (former Millipore A/S),,,,Regnskabsklasse B,The annual report has been prepared in accordance with the Danish Financial Statements Act.,"It is our opinion that the financial statements give a true and fair view of the Company's assets, liabilities and financial position at 31 December 2014 and of the result of the Company's operations  for the year 1 January - 31 December 2014.",,2015-05-29,1982-12-31,2015-05-29,Proposed dividends are recognised as a liability at the date when they are adopted at the annual general meeting (declaration date). The expected dividend payment for the year is disclosed as a separate item under equity.,Staff expenses comprise wages and salaries as well as payroll expenses.,"Interest income and interest expenses comprise interest income and expense, gains and losses on payables and transactions denominated in foreign currencies, amortisation of financial assets and liabilities as well as surcharges and refunds under the on-account tax scheme. etc.",Financial liabilities are measured at amortised cost. Other liabilities are measured at net realisable value.,"Other external expenses comprise expenses incurred for travelling, administration and other external expenses.",Receivables are measured at amortised cost. Provision is made for anticipated losses at net realisable value.,,,,www.millipore.com,25578198.0,73131510.0,25578198.0,The Executive and the Board of Directors have today discussed and approved the annual report of Merck Life Science A/S (former Millipore A/S) for the financial year 1 January - 31 December 2014.,"We have audited the financial statements of Merck Life Science A/S (former Millipore A/S) for the financial year 1 January - 31 December 2014. The financial statements comprise accounting policies, income statement, balance sheet and notes. The financial statements are prepared in accordance with the Danish Financial Statements Act.",Ãrsrapport,"In our opinion, the Management's review includes a fair review of the development in the Company's operations and financial conditions, the result for the year and the financial position.",Susanne Krogh,Hans Christopher Elers Koch,Merck Life Science A/S (former Millipore A/S),KPMG,"In our opinion, the financial statements give a true and fair view of the Company's financial position at 31 December 2014 and of the results of the Company's operations for the financial year 1 January - 31 December 2014 in accordance with the Danish Financial Statements Act.",,,,,,,Copenhagen,2014-12-31,2014-01-01,Copenhagen,,"Management is responsible for the preparation and presentation of financial statements that give a true and fair view in accordance with the Danish Financial Statements Act and for such internal control that Management determines is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.","Pursuant to the Danish Financial Statements Act, we have read the Management's review. We have not performed any further procedures in addition to the audit of the financial statements. On this basis, it is our opinion that the information provided in the Management's review is consistent with the financial statements.","Without modifying our opinion, we draw attention to the fact that the Company does not comply with the requirements of the Danish Bookkeeping Act on preservation of accounting records.",,70707760.0,+45 70 10 56 45,RevisionspÃ¥tegning,,urn:ofk:oid:5447722,indberetninger-20180424,2.5118535,73131510.0,,2018-03-30T13:09:18.582Z,2015-06-04T10:08:14.884Z,regnskab,0.0,,2014-12-31,2014-01-01,X15-AD-15-AL,2015-06-04T10:08:15.276Z,,,,,,,12347000.0,,,,,,,,,,,,,,,,,
73131510,2014-01-01,2014-12-31,c104,,http://regnskaber.virk.dk/01513137/ZG9rdW1lbnRsYWdlcjovLzAzL2ZkLzBlLzhiLzljLzA1YWEtNDVlZi05OWJjLTQxNDg1OTVhNGZiNw.pdf,http://regnskaber.virk.dk/01513137/ZG9rdW1lbnRsYWdlcjovLzAzLzQ4Lzk5LzI4L2I4LzkyZjctNDA2MC04ZTE4LWRjZTk5ZjZhN2YyNQ.xml,Danmark,DK,Copenhagen,2100.0,38.0,Amerika Plads,Danmark,DK,Hellerup,DK-2900,102 E,Strandvejen,2100 KÃ¸benhavn Ã,Amerika Plads 38,To the Shareholder of Merck Life Science A/S (former Millipore A/S),,,,Regnskabsklasse B,The annual report has been prepared in accordance with the Danish Financial Statements Act.,"It is our opinion that the financial statements give a true and fair view of the Company's assets, liabilities and financial position at 31 December 2014 and of the result of the Company's operations  for the year 1 January - 31 December 2014.",,2015-05-29,1982-12-31,2015-05-29,Proposed dividends are recognised as a liability at the date when they are adopted at the annual general meeting (declaration date). The expected dividend payment for the year is disclosed as a separate item under equity.,Staff expenses comprise wages and salaries as well as payroll expenses.,"Interest income and interest expenses comprise interest income and expense, gains and losses on payables and transactions denominated in foreign currencies, amortisation of financial assets and liabilities as well as surcharges and refunds under the on-account tax scheme. etc.",Financial liabilities are measured at amortised cost. Other liabilities are measured at net realisable value.,"Other external expenses comprise expenses incurred for travelling, administration and other external expenses.",Receivables are measured at amortised cost. Provision is made for anticipated losses at net realisable value.,,,,www.millipore.com,25578198.0,73131510.0,25578198.0,The Executive and the Board of Directors have today discussed and approved the annual report of Merck Life Science A/S (former Millipore A/S) for the financial year 1 January - 31 December 2014.,"We have audited the financial statements of Merck Life Science A/S (former Millipore A/S) for the financial year 1 January - 31 December 2014. The financial statements comprise accounting policies, income statement, balance sheet and notes. The financial statements are prepared in accordance with the Danish Financial Statements Act.",Ãrsrapport,"In our opinion, the Management's review includes a fair review of the development in the Company's operations and financial conditions, the result for the year and the financial position.",Susanne Krogh,Hans Christopher Elers Koch,Merck Life Science A/S (former Millipore A/S),KPMG,"In our opinion, the financial statements give a true and fair view of the Company's financial position at 31 December 2014 and of the results of the Company's operations for the financial year 1 January - 31 December 2014 in accordance with the Danish Financial Statements Act.",,,,,,,Copenhagen,2014-12-31,2014-01-01,Copenhagen,,"Management is responsible for the preparation and presentation of financial statements that give a true and fair view in accordance with the Danish Financial Statements Act and for such internal control that Management determines is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.","Pursuant to the Danish Financial Statements Act, we have read the Management's review. We have not performed any further procedures in addition to the audit of the financial statements. On this basis, it is our opinion that the information provided in the Management's review is consistent with the financial statements.","Without modifying our opinion, we draw attention to the fact that the Company does not comply with the requirements of the Danish Bookkeeping Act on preservation of accounting records.",,70707760.0,+45 70 10 56 45,RevisionspÃ¥tegning,,urn:ofk:oid:5447722,indberetninger-20180424,2.5118535,73131510.0,,2018-03-30T13:09:18.582Z,2015-06-04T10:08:14.884Z,regnskab,0.0,,2014-12-31,2014-01-01,X15-AD-15-AL,2015-06-04T10:08:15.276Z,,,,,,,,,,,,,,,,,,,,,,,,
73131510,2014-01-01,2014-12-31,c11,,http://regnskaber.virk.dk/01513137/ZG9rdW1lbnRsYWdlcjovLzAzL2ZkLzBlLzhiLzljLzA1YWEtNDVlZi05OWJjLTQxNDg1OTVhNGZiNw.pdf,http://regnskaber.virk.dk/01513137/ZG9rdW1lbnRsYWdlcjovLzAzLzQ4Lzk5LzI4L2I4LzkyZjctNDA2MC04ZTE4LWRjZTk5ZjZhN2YyNQ.xml,Danmark,DK,Copenhagen,2100.0,38.0,Amerika Plads,Danmark,DK,Hellerup,DK-2900,102 E,Strandvejen,2100 KÃ¸benhavn Ã,Amerika Plads 38,To the Shareholder of Merck Life Science A/S (former Millipore A/S),198000.0,-7000.0,7.0,Regnskabsklasse B,The annual report has been prepared in accordance with the Danish Financial Statements Act.,"It is our opinion that the financial statements give a true and fair view of the Company's assets, liabilities and financial position at 31 December 2014 and of the result of the Company's operations  for the year 1 January - 31 December 2014.",988000.0,2015-05-29,1982-12-31,2015-05-29,Proposed dividends are recognised as a liability at the date when they are adopted at the annual general meeting (declaration date). The expected dividend payment for the year is disclosed as a separate item under equity.,Staff expenses comprise wages and salaries as well as payroll expenses.,"Interest income and interest expenses comprise interest income and expense, gains and losses on payables and transactions denominated in foreign currencies, amortisation of financial assets and liabilities as well as surcharges and refunds under the on-account tax scheme. etc.",Financial liabilities are measured at amortised cost. Other liabilities are measured at net realisable value.,"Other external expenses comprise expenses incurred for travelling, administration and other external expenses.",Receivables are measured at amortised cost. Provision is made for anticipated losses at net realisable value.,6902000.0,0.0,10213000.0,www.millipore.com,25578198.0,73131510.0,25578198.0,The Executive and the Board of Directors have today discussed and approved the annual report of Merck Life Science A/S (former Millipore A/S) for the financial year 1 January - 31 December 2014.,"We have audited the financial statements of Merck Life Science A/S (former Millipore A/S) for the financial year 1 January - 31 December 2014. The financial statements comprise accounting policies, income statement, balance sheet and notes. The financial statements are prepared in accordance with the Danish Financial Statements Act.",Ãrsrapport,"In our opinion, the Management's review includes a fair review of the development in the Company's operations and financial conditions, the result for the year and the financial position.",Susanne Krogh,Hans Christopher Elers Koch,Merck Life Science A/S (former Millipore A/S),KPMG,"In our opinion, the financial statements give a true and fair view of the Company's financial position at 31 December 2014 and of the results of the Company's operations for the financial year 1 January - 31 December 2014 in accordance with the Danish Financial Statements Act.",21000.0,21000.0,535000.0,2111000.0,3290000.0,3311000.0,Copenhagen,2014-12-31,2014-01-01,Copenhagen,24000.0,"Management is responsible for the preparation and presentation of financial statements that give a true and fair view in accordance with the Danish Financial Statements Act and for such internal control that Management determines is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.","Pursuant to the Danish Financial Statements Act, we have read the Management's review. We have not performed any further procedures in addition to the audit of the financial statements. On this basis, it is our opinion that the information provided in the Management's review is consistent with the financial statements.","Without modifying our opinion, we draw attention to the fact that the Company does not comply with the requirements of the Danish Bookkeeping Act on preservation of accounting records.",1179000.0,70707760.0,+45 70 10 56 45,RevisionspÃ¥tegning,6343000.0,urn:ofk:oid:5447722,indberetninger-20180424,2.5118535,73131510.0,,2018-03-30T13:09:18.582Z,2015-06-04T10:08:14.884Z,regnskab,0.0,,2014-12-31,2014-01-01,X15-AD-15-AL,2015-06-04T10:08:15.276Z,,,,,,,,,,,,,,,,,,,,,,,,
73131510,2014-01-01,2014-12-31,c12,,http://regnskaber.virk.dk/01513137/ZG9rdW1lbnRsYWdlcjovLzAzL2ZkLzBlLzhiLzljLzA1YWEtNDVlZi05OWJjLTQxNDg1OTVhNGZiNw.pdf,http://regnskaber.virk.dk/01513137/ZG9rdW1lbnRsYWdlcjovLzAzLzQ4Lzk5LzI4L2I4LzkyZjctNDA2MC04ZTE4LWRjZTk5ZjZhN2YyNQ.xml,Danmark,DK,Copenhagen,2100.0,38.0,Amerika Plads,Danmark,DK,Hellerup,DK-2900,102 E,Strandvejen,2100 KÃ¸benhavn Ã,Amerika Plads 38,To the Shareholder of Merck Life Science A/S (former Millipore A/S),,,,Regnskabsklasse B,The annual report has been prepared in accordance with the Danish Financial Statements Act.,"It is our opinion that the financial statements give a true and fair view of the Company's assets, liabilities and financial position at 31 December 2014 and of the result of the Company's operations  for the year 1 January - 31 December 2014.",,2015-05-29,1982-12-31,2015-05-29,Proposed dividends are recognised as a liability at the date when they are adopted at the annual general meeting (declaration date). The expected dividend payment for the year is disclosed as a separate item under equity.,Staff expenses comprise wages and salaries as well as payroll expenses.,"Interest income and interest expenses comprise interest income and expense, gains and losses on payables and transactions denominated in foreign currencies, amortisation of financial assets and liabilities as well as surcharges and refunds under the on-account tax scheme. etc.",Financial liabilities are measured at amortised cost. Other liabilities are measured at net realisable value.,"Other external expenses comprise expenses incurred for travelling, administration and other external expenses.",Receivables are measured at amortised cost. Provision is made for anticipated losses at net realisable value.,,,,www.millipore.com,25578198.0,73131510.0,25578198.0,The Executive and the Board of Directors have today discussed and approved the annual report of Merck Life Science A/S (former Millipore A/S) for the financial year 1 January - 31 December 2014.,"We have audited the financial statements of Merck Life Science A/S (former Millipore A/S) for the financial year 1 January - 31 December 2014. The financial statements comprise accounting policies, income statement, balance sheet and notes. The financial statements are prepared in accordance with the Danish Financial Statements Act.",Ãrsrapport,"In our opinion, the Management's review includes a fair review of the development in the Company's operations and financial conditions, the result for the year and the financial position.",Susanne Krogh,Hans Christopher Elers Koch,Merck Life Science A/S (former Millipore A/S),KPMG,"In our opinion, the financial statements give a true and fair view of the Company's financial position at 31 December 2014 and of the results of the Company's operations for the financial year 1 January - 31 December 2014 in accordance with the Danish Financial Statements Act.",,,,,,,Copenhagen,2014-12-31,2014-01-01,Copenhagen,,"Management is responsible for the preparation and presentation of financial statements that give a true and fair view in accordance with the Danish Financial Statements Act and for such internal control that Management determines is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.","Pursuant to the Danish Financial Statements Act, we have read the Management's review. We have not performed any further procedures in addition to the audit of the financial statements. On this basis, it is our opinion that the information provided in the Management's review is consistent with the financial statements.","Without modifying our opinion, we draw attention to the fact that the Company does not comply with the requirements of the Danish Bookkeeping Act on preservation of accounting records.",,70707760.0,+45 70 10 56 45,RevisionspÃ¥tegning,,urn:ofk:oid:5447722,indberetninger-20180424,2.5118535,73131510.0,,2018-03-30T13:09:18.582Z,2015-06-04T10:08:14.884Z,regnskab,0.0,,2014-12-31,2014-01-01,X15-AD-15-AL,2015-06-04T10:08:15.276Z,,,,,,,,,,,,,,,,,,,,,,Casper Garrelts,KPMG,
73131510,2014-01-01,2014-12-31,c132,,http://regnskaber.virk.dk/01513137/ZG9rdW1lbnRsYWdlcjovLzAzL2ZkLzBlLzhiLzljLzA1YWEtNDVlZi05OWJjLTQxNDg1OTVhNGZiNw.pdf,http://regnskaber.virk.dk/01513137/ZG9rdW1lbnRsYWdlcjovLzAzLzQ4Lzk5LzI4L2I4LzkyZjctNDA2MC04ZTE4LWRjZTk5ZjZhN2YyNQ.xml,Danmark,DK,Copenhagen,2100.0,38.0,Amerika Plads,Danmark,DK,Hellerup,DK-2900,102 E,Strandvejen,2100 KÃ¸benhavn Ã,Amerika Plads 38,To the Shareholder of Merck Life Science A/S (former Millipore A/S),,,,Regnskabsklasse B,The annual report has been prepared in accordance with the Danish Financial Statements Act.,"It is our opinion that the financial statements give a true and fair view of the Company's assets, liabilities and financial position at 31 December 2014 and of the result of the Company's operations  for the year 1 January - 31 December 2014.",,2015-05-29,1982-12-31,2015-05-29,Proposed dividends are recognised as a liability at the date when they are adopted at the annual general meeting (declaration date). The expected dividend payment for the year is disclosed as a separate item under equity.,Staff expenses comprise wages and salaries as well as payroll expenses.,"Interest income and interest expenses comprise interest income and expense, gains and losses on payables and transactions denominated in foreign currencies, amortisation of financial assets and liabilities as well as surcharges and refunds under the on-account tax scheme. etc.",Financial liabilities are measured at amortised cost. Other liabilities are measured at net realisable value.,"Other external expenses comprise expenses incurred for travelling, administration and other external expenses.",Receivables are measured at amortised cost. Provision is made for anticipated losses at net realisable value.,,,,www.millipore.com,25578198.0,73131510.0,25578198.0,The Executive and the Board of Directors have today discussed and approved the annual report of Merck Life Science A/S (former Millipore A/S) for the financial year 1 January - 31 December 2014.,"We have audited the financial statements of Merck Life Science A/S (former Millipore A/S) for the financial year 1 January - 31 December 2014. The financial statements comprise accounting policies, income statement, balance sheet and notes. The financial statements are prepared in accordance with the Danish Financial Statements Act.",Ãrsrapport,"In our opinion, the Management's review includes a fair review of the development in the Company's operations and financial conditions, the result for the year and the financial position.",Susanne Krogh,Hans Christopher Elers Koch,Merck Life Science A/S (former Millipore A/S),KPMG,"In our opinion, the financial statements give a true and fair view of the Company's financial position at 31 December 2014 and of the results of the Company's operations for the financial year 1 January - 31 December 2014 in accordance with the Danish Financial Statements Act.",,,,2111000.0,,,Copenhagen,2014-12-31,2014-01-01,Copenhagen,,"Management is responsible for the preparation and presentation of financial statements that give a true and fair view in accordance with the Danish Financial Statements Act and for such internal control that Management determines is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.","Pursuant to the Danish Financial Statements Act, we have read the Management's review. We have not performed any further procedures in addition to the audit of the financial statements. On this basis, it is our opinion that the information provided in the Management's review is consistent with the financial statements.","Without modifying our opinion, we draw attention to the fact that the Company does not comply with the requirements of the Danish Bookkeeping Act on preservation of accounting records.",,70707760.0,+45 70 10 56 45,RevisionspÃ¥tegning,,urn:ofk:oid:5447722,indberetninger-20180424,2.5118535,73131510.0,,2018-03-30T13:09:18.582Z,2015-06-04T10:08:14.884Z,regnskab,0.0,,2014-12-31,2014-01-01,X15-AD-15-AL,2015-06-04T10:08:15.276Z,,,,,,,,,,,,,,,,,,,,,,,,
73131510,2014-01-01,2014-12-31,c72,,http://regnskaber.virk.dk/01513137/ZG9rdW1lbnRsYWdlcjovLzAzL2ZkLzBlLzhiLzljLzA1YWEtNDVlZi05OWJjLTQxNDg1OTVhNGZiNw.pdf,http://regnskaber.virk.dk/01513137/ZG9rdW1lbnRsYWdlcjovLzAzLzQ4Lzk5LzI4L2I4LzkyZjctNDA2MC04ZTE4LWRjZTk5ZjZhN2YyNQ.xml,Danmark,DK,Copenhagen,2100.0,38.0,Amerika Plads,Danmark,DK,Hellerup,DK-2900,102 E,Strandvejen,2100 KÃ¸benhavn Ã,Amerika Plads 38,To the Shareholder of Merck Life Science A/S (former Millipore A/S),,,,Regnskabsklasse B,The annual report has been prepared in accordance with the Danish Financial Statements Act.,"It is our opinion that the financial statements give a true and fair view of the Company's assets, liabilities and financial position at 31 December 2014 and of the result of the Company's operations  for the year 1 January - 31 December 2014.",,2015-05-29,1982-12-31,2015-05-29,Proposed dividends are recognised as a liability at the date when they are adopted at the annual general meeting (declaration date). The expected dividend payment for the year is disclosed as a separate item under equity.,Staff expenses comprise wages and salaries as well as payroll expenses.,"Interest income and interest expenses comprise interest income and expense, gains and losses on payables and transactions denominated in foreign currencies, amortisation of financial assets and liabilities as well as surcharges and refunds under the on-account tax scheme. etc.",Financial liabilities are measured at amortised cost. Other liabilities are measured at net realisable value.,"Other external expenses comprise expenses incurred for travelling, administration and other external expenses.",Receivables are measured at amortised cost. Provision is made for anticipated losses at net realisable value.,,,,www.millipore.com,25578198.0,73131510.0,25578198.0,The Executive and the Board of Directors have today discussed and approved the annual report of Merck Life Science A/S (former Millipore A/S) for the financial year 1 January - 31 December 2014.,"We have audited the financial statements of Merck Life Science A/S (former Millipore A/S) for the financial year 1 January - 31 December 2014. The financial statements comprise accounting policies, income statement, balance sheet and notes. The financial statements are prepared in accordance with the Danish Financial Statements Act.",Ãrsrapport,"In our opinion, the Management's review includes a fair review of the development in the Company's operations and financial conditions, the result for the year and the financial position.",Susanne Krogh,Hans Christopher Elers Koch,Merck Life Science A/S (former Millipore A/S),KPMG,"In our opinion, the financial statements give a true and fair view of the Company's financial position at 31 December 2014 and of the results of the Company's operations for the financial year 1 January - 31 December 2014 in accordance with the Danish Financial Statements Act.",,,,2111000.0,,,Copenhagen,2014-12-31,2014-01-01,Copenhagen,,"Management is responsible for the preparation and presentation of financial statements that give a true and fair view in accordance with the Danish Financial Statements Act and for such internal control that Management determines is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.","Pursuant to the Danish Financial Statements Act, we have read the Management's review. We have not performed any further procedures in addition to the audit of the financial statements. On this basis, it is our opinion that the information provided in the Management's review is consistent with the financial statements.","Without modifying our opinion, we draw attention to the fact that the Company does not comply with the requirements of the Danish Bookkeeping Act on preservation of accounting records.",,70707760.0,+45 70 10 56 45,RevisionspÃ¥tegning,,urn:ofk:oid:5447722,indberetninger-20180424,2.5118535,73131510.0,,2018-03-30T13:09:18.582Z,2015-06-04T10:08:14.884Z,regnskab,0.0,,2014-12-31,2014-01-01,X15-AD-15-AL,2015-06-04T10:08:15.276Z,,,,,,,,,,,,,,,,,,,,,,,,
73131510,2014-01-01,2014-12-31,c89,,http://regnskaber.virk.dk/01513137/ZG9rdW1lbnRsYWdlcjovLzAzL2ZkLzBlLzhiLzljLzA1YWEtNDVlZi05OWJjLTQxNDg1OTVhNGZiNw.pdf,http://regnskaber.virk.dk/01513137/ZG9rdW1lbnRsYWdlcjovLzAzLzQ4Lzk5LzI4L2I4LzkyZjctNDA2MC04ZTE4LWRjZTk5ZjZhN2YyNQ.xml,Danmark,DK,Copenhagen,2100.0,38.0,Amerika Plads,Danmark,DK,Hellerup,DK-2900,102 E,Strandvejen,2100 KÃ¸benhavn Ã,Amerika Plads 38,To the Shareholder of Merck Life Science A/S (former Millipore A/S),,,,Regnskabsklasse B,The annual report has been prepared in accordance with the Danish Financial Statements Act.,"It is our opinion that the financial statements give a true and fair view of the Company's assets, liabilities and financial position at 31 December 2014 and of the result of the Company's operations  for the year 1 January - 31 December 2014.",,2015-05-29,1982-12-31,2015-05-29,Proposed dividends are recognised as a liability at the date when they are adopted at the annual general meeting (declaration date). The expected dividend payment for the year is disclosed as a separate item under equity.,Staff expenses comprise wages and salaries as well as payroll expenses.,"Interest income and interest expenses comprise interest income and expense, gains and losses on payables and transactions denominated in foreign currencies, amortisation of financial assets and liabilities as well as surcharges and refunds under the on-account tax scheme. etc.",Financial liabilities are measured at amortised cost. Other liabilities are measured at net realisable value.,"Other external expenses comprise expenses incurred for travelling, administration and other external expenses.",Receivables are measured at amortised cost. Provision is made for anticipated losses at net realisable value.,,,,www.millipore.com,25578198.0,73131510.0,25578198.0,The Executive and the Board of Directors have today discussed and approved the annual report of Merck Life Science A/S (former Millipore A/S) for the financial year 1 January - 31 December 2014.,"We have audited the financial statements of Merck Life Science A/S (former Millipore A/S) for the financial year 1 January - 31 December 2014. The financial statements comprise accounting policies, income statement, balance sheet and notes. The financial statements are prepared in accordance with the Danish Financial Statements Act.",Ãrsrapport,"In our opinion, the Management's review includes a fair review of the development in the Company's operations and financial conditions, the result for the year and the financial position.",Susanne Krogh,Hans Christopher Elers Koch,Merck Life Science A/S (former Millipore A/S),KPMG,"In our opinion, the financial statements give a true and fair view of the Company's financial position at 31 December 2014 and of the results of the Company's operations for the financial year 1 January - 31 December 2014 in accordance with the Danish Financial Statements Act.",,,,,,,Copenhagen,2014-12-31,2014-01-01,Copenhagen,,"Management is responsible for the preparation and presentation of financial statements that give a true and fair view in accordance with the Danish Financial Statements Act and for such internal control that Management determines is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.","Pursuant to the Danish Financial Statements Act, we have read the Management's review. We have not performed any further procedures in addition to the audit of the financial statements. On this basis, it is our opinion that the information provided in the Management's review is consistent with the financial statements.","Without modifying our opinion, we draw attention to the fact that the Company does not comply with the requirements of the Danish Bookkeeping Act on preservation of accounting records.",,70707760.0,+45 70 10 56 45,RevisionspÃ¥tegning,,urn:ofk:oid:5447722,indberetninger-20180424,2.5118535,73131510.0,,2018-03-30T13:09:18.582Z,2015-06-04T10:08:14.884Z,regnskab,0.0,,2014-12-31,2014-01-01,X15-AD-15-AL,2015-06-04T10:08:15.276Z,,,,,,,,,,,,,,,,,,,,,,,,Sven HÃ¥kan Englund
73131510,2014-01-01,2014-12-31,c90,,http://regnskaber.virk.dk/01513137/ZG9rdW1lbnRsYWdlcjovLzAzL2ZkLzBlLzhiLzljLzA1YWEtNDVlZi05OWJjLTQxNDg1OTVhNGZiNw.pdf,http://regnskaber.virk.dk/01513137/ZG9rdW1lbnRsYWdlcjovLzAzLzQ4Lzk5LzI4L2I4LzkyZjctNDA2MC04ZTE4LWRjZTk5ZjZhN2YyNQ.xml,Danmark,DK,Copenhagen,2100.0,38.0,Amerika Plads,Danmark,DK,Hellerup,DK-2900,102 E,Strandvejen,2100 KÃ¸benhavn Ã,Amerika Plads 38,To the Shareholder of Merck Life Science A/S (former Millipore A/S),,,,Regnskabsklasse B,The annual report has been prepared in accordance with the Danish Financial Statements Act.,"It is our opinion that the financial statements give a true and fair view of the Company's assets, liabilities and financial position at 31 December 2014 and of the result of the Company's operations  for the year 1 January - 31 December 2014.",,2015-05-29,1982-12-31,2015-05-29,Proposed dividends are recognised as a liability at the date when they are adopted at the annual general meeting (declaration date). The expected dividend payment for the year is disclosed as a separate item under equity.,Staff expenses comprise wages and salaries as well as payroll expenses.,"Interest income and interest expenses comprise interest income and expense, gains and losses on payables and transactions denominated in foreign currencies, amortisation of financial assets and liabilities as well as surcharges and refunds under the on-account tax scheme. etc.",Financial liabilities are measured at amortised cost. Other liabilities are measured at net realisable value.,"Other external expenses comprise expenses incurred for travelling, administration and other external expenses.",Receivables are measured at amortised cost. Provision is made for anticipated losses at net realisable value.,,,,www.millipore.com,25578198.0,73131510.0,25578198.0,The Executive and the Board of Directors have today discussed and approved the annual report of Merck Life Science A/S (former Millipore A/S) for the financial year 1 January - 31 December 2014.,"We have audited the financial statements of Merck Life Science A/S (former Millipore A/S) for the financial year 1 January - 31 December 2014. The financial statements comprise accounting policies, income statement, balance sheet and notes. The financial statements are prepared in accordance with the Danish Financial Statements Act.",Ãrsrapport,"In our opinion, the Management's review includes a fair review of the development in the Company's operations and financial conditions, the result for the year and the financial position.",Susanne Krogh,Hans Christopher Elers Koch,Merck Life Science A/S (former Millipore A/S),KPMG,"In our opinion, the financial statements give a true and fair view of the Company's financial position at 31 December 2014 and of the results of the Company's operations for the financial year 1 January - 31 December 2014 in accordance with the Danish Financial Statements Act.",,,,,,,Copenhagen,2014-12-31,2014-01-01,Copenhagen,,"Management is responsible for the preparation and presentation of financial statements that give a true and fair view in accordance with the Danish Financial Statements Act and for such internal control that Management determines is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.","Pursuant to the Danish Financial Statements Act, we have read the Management's review. We have not performed any further procedures in addition to the audit of the financial statements. On this basis, it is our opinion that the information provided in the Management's review is consistent with the financial statements.","Without modifying our opinion, we draw attention to the fact that the Company does not comply with the requirements of the Danish Bookkeeping Act on preservation of accounting records.",,70707760.0,+45 70 10 56 45,RevisionspÃ¥tegning,,urn:ofk:oid:5447722,indberetninger-20180424,2.5118535,73131510.0,,2018-03-30T13:09:18.582Z,2015-06-04T10:08:14.884Z,regnskab,0.0,,2014-12-31,2014-01-01,X15-AD-15-AL,2015-06-04T10:08:15.276Z,,,,,,,,,,,,,,,,,,,,,,,,Hans Christopher Elers Koch
73131510,2014-01-01,2014-12-31,c91,,http://regnskaber.virk.dk/01513137/ZG9rdW1lbnRsYWdlcjovLzAzL2ZkLzBlLzhiLzljLzA1YWEtNDVlZi05OWJjLTQxNDg1OTVhNGZiNw.pdf,http://regnskaber.virk.dk/01513137/ZG9rdW1lbnRsYWdlcjovLzAzLzQ4Lzk5LzI4L2I4LzkyZjctNDA2MC04ZTE4LWRjZTk5ZjZhN2YyNQ.xml,Danmark,DK,Copenhagen,2100.0,38.0,Amerika Plads,Danmark,DK,Hellerup,DK-2900,102 E,Strandvejen,2100 KÃ¸benhavn Ã,Amerika Plads 38,To the Shareholder of Merck Life Science A/S (former Millipore A/S),,,,Regnskabsklasse B,The annual report has been prepared in accordance with the Danish Financial Statements Act.,"It is our opinion that the financial statements give a true and fair view of the Company's assets, liabilities and financial position at 31 December 2014 and of the result of the Company's operations  for the year 1 January - 31 December 2014.",,2015-05-29,1982-12-31,2015-05-29,Proposed dividends are recognised as a liability at the date when they are adopted at the annual general meeting (declaration date). The expected dividend payment for the year is disclosed as a separate item under equity.,Staff expenses comprise wages and salaries as well as payroll expenses.,"Interest income and interest expenses comprise interest income and expense, gains and losses on payables and transactions denominated in foreign currencies, amortisation of financial assets and liabilities as well as surcharges and refunds under the on-account tax scheme. etc.",Financial liabilities are measured at amortised cost. Other liabilities are measured at net realisable value.,"Other external expenses comprise expenses incurred for travelling, administration and other external expenses.",Receivables are measured at amortised cost. Provision is made for anticipated losses at net realisable value.,,,,www.millipore.com,25578198.0,73131510.0,25578198.0,The Executive and the Board of Directors have today discussed and approved the annual report of Merck Life Science A/S (former Millipore A/S) for the financial year 1 January - 31 December 2014.,"We have audited the financial statements of Merck Life Science A/S (former Millipore A/S) for the financial year 1 January - 31 December 2014. The financial statements comprise accounting policies, income statement, balance sheet and notes. The financial statements are prepared in accordance with the Danish Financial Statements Act.",Ãrsrapport,"In our opinion, the Management's review includes a fair review of the development in the Company's operations and financial conditions, the result for the year and the financial position.",Susanne Krogh,Hans Christopher Elers Koch,Merck Life Science A/S (former Millipore A/S),KPMG,"In our opinion, the financial statements give a true and fair view of the Company's financial position at 31 December 2014 and of the results of the Company's operations for the financial year 1 January - 31 December 2014 in accordance with the Danish Financial Statements Act.",,,,,,,Copenhagen,2014-12-31,2014-01-01,Copenhagen,,"Management is responsible for the preparation and presentation of financial statements that give a true and fair view in accordance with the Danish Financial Statements Act and for such internal control that Management determines is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.","Pursuant to the Danish Financial Statements Act, we have read the Management's review. We have not performed any further procedures in addition to the audit of the financial statements. On this basis, it is our opinion that the information provided in the Management's review is consistent with the financial statements.","Without modifying our opinion, we draw attention to the fact that the Company does not comply with the requirements of the Danish Bookkeeping Act on preservation of accounting records.",,70707760.0,+45 70 10 56 45,RevisionspÃ¥tegning,,urn:ofk:oid:5447722,indberetninger-20180424,2.5118535,73131510.0,,2018-03-30T13:09:18.582Z,2015-06-04T10:08:14.884Z,regnskab,0.0,,2014-12-31,2014-01-01,X15-AD-15-AL,2015-06-04T10:08:15.276Z,,,,,,,,,,,,,,,,,,,,,,,,Jeanette Sandholmen
73131510,2014-12-31,2014-12-31,c115,,http://regnskaber.virk.dk/01513137/ZG9rdW1lbnRsYWdlcjovLzAzL2ZkLzBlLzhiLzljLzA1YWEtNDVlZi05OWJjLTQxNDg1OTVhNGZiNw.pdf,http://regnskaber.virk.dk/01513137/ZG9rdW1lbnRsYWdlcjovLzAzLzQ4Lzk5LzI4L2I4LzkyZjctNDA2MC04ZTE4LWRjZTk5ZjZhN2YyNQ.xml,Danmark,DK,Copenhagen,2100.0,38.0,Amerika Plads,Danmark,DK,Hellerup,DK-2900,102 E,Strandvejen,2100 KÃ¸benhavn Ã,Amerika Plads 38,To the Shareholder of Merck Life Science A/S (former Millipore A/S),,,,Regnskabsklasse B,The annual report has been prepared in accordance with the Danish Financial Statements Act.,"It is our opinion that the financial statements give a true and fair view of the Company's assets, liabilities and financial position at 31 December 2014 and of the result of the Company's operations  for the year 1 January - 31 December 2014.",,2015-05-29,1982-12-31,2015-05-29,Proposed dividends are recognised as a liability at the date when they are adopted at the annual general meeting (declaration date). The expected dividend payment for the year is disclosed as a separate item under equity.,Staff expenses comprise wages and salaries as well as payroll expenses.,"Interest income and interest expenses comprise interest income and expense, gains and losses on payables and transactions denominated in foreign currencies, amortisation of financial assets and liabilities as well as surcharges and refunds under the on-account tax scheme. etc.",Financial liabilities are measured at amortised cost. Other liabilities are measured at net realisable value.,"Other external expenses comprise expenses incurred for travelling, administration and other external expenses.",Receivables are measured at amortised cost. Provision is made for anticipated losses at net realisable value.,,,,www.millipore.com,25578198.0,73131510.0,25578198.0,The Executive and the Board of Directors have today discussed and approved the annual report of Merck Life Science A/S (former Millipore A/S) for the financial year 1 January - 31 December 2014.,"We have audited the financial statements of Merck Life Science A/S (former Millipore A/S) for the financial year 1 January - 31 December 2014. The financial statements comprise accounting policies, income statement, balance sheet and notes. The financial statements are prepared in accordance with the Danish Financial Statements Act.",Ãrsrapport,"In our opinion, the Management's review includes a fair review of the development in the Company's operations and financial conditions, the result for the year and the financial position.",Susanne Krogh,Hans Christopher Elers Koch,Merck Life Science A/S (former Millipore A/S),KPMG,"In our opinion, the financial statements give a true and fair view of the Company's financial position at 31 December 2014 and of the results of the Company's operations for the financial year 1 January - 31 December 2014 in accordance with the Danish Financial Statements Act.",,,,,,,Copenhagen,2014-12-31,2014-01-01,Copenhagen,,"Management is responsible for the preparation and presentation of financial statements that give a true and fair view in accordance with the Danish Financial Statements Act and for such internal control that Management determines is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.","Pursuant to the Danish Financial Statements Act, we have read the Management's review. We have not performed any further procedures in addition to the audit of the financial statements. On this basis, it is our opinion that the information provided in the Management's review is consistent with the financial statements.","Without modifying our opinion, we draw attention to the fact that the Company does not comply with the requirements of the Danish Bookkeeping Act on preservation of accounting records.",,70707760.0,+45 70 10 56 45,RevisionspÃ¥tegning,,urn:ofk:oid:5447722,indberetninger-20180424,2.5118535,73131510.0,,2018-03-30T13:09:18.582Z,2015-06-04T10:08:14.884Z,regnskab,0.0,,2014-12-31,2014-01-01,X15-AD-15-AL,2015-06-04T10:08:15.276Z,,,,,,,2000000.0,,,,,,,,,,,,,,,,,
73131510,2014-12-31,2014-12-31,c133,,http://regnskaber.virk.dk/01513137/ZG9rdW1lbnRsYWdlcjovLzAzL2ZkLzBlLzhiLzljLzA1YWEtNDVlZi05OWJjLTQxNDg1OTVhNGZiNw.pdf,http://regnskaber.virk.dk/01513137/ZG9rdW1lbnRsYWdlcjovLzAzLzQ4Lzk5LzI4L2I4LzkyZjctNDA2MC04ZTE4LWRjZTk5ZjZhN2YyNQ.xml,Danmark,DK,Copenhagen,2100.0,38.0,Amerika Plads,Danmark,DK,Hellerup,DK-2900,102 E,Strandvejen,2100 KÃ¸benhavn Ã,Amerika Plads 38,To the Shareholder of Merck Life Science A/S (former Millipore A/S),,,,Regnskabsklasse B,The annual report has been prepared in accordance with the Danish Financial Statements Act.,"It is our opinion that the financial statements give a true and fair view of the Company's assets, liabilities and financial position at 31 December 2014 and of the result of the Company's operations  for the year 1 January - 31 December 2014.",,2015-05-29,1982-12-31,2015-05-29,Proposed dividends are recognised as a liability at the date when they are adopted at the annual general meeting (declaration date). The expected dividend payment for the year is disclosed as a separate item under equity.,Staff expenses comprise wages and salaries as well as payroll expenses.,"Interest income and interest expenses comprise interest income and expense, gains and losses on payables and transactions denominated in foreign currencies, amortisation of financial assets and liabilities as well as surcharges and refunds under the on-account tax scheme. etc.",Financial liabilities are measured at amortised cost. Other liabilities are measured at net realisable value.,"Other external expenses comprise expenses incurred for travelling, administration and other external expenses.",Receivables are measured at amortised cost. Provision is made for anticipated losses at net realisable value.,,,,www.millipore.com,25578198.0,73131510.0,25578198.0,The Executive and the Board of Directors have today discussed and approved the annual report of Merck Life Science A/S (former Millipore A/S) for the financial year 1 January - 31 December 2014.,"We have audited the financial statements of Merck Life Science A/S (former Millipore A/S) for the financial year 1 January - 31 December 2014. The financial statements comprise accounting policies, income statement, balance sheet and notes. The financial statements are prepared in accordance with the Danish Financial Statements Act.",Ãrsrapport,"In our opinion, the Management's review includes a fair review of the development in the Company's operations and financial conditions, the result for the year and the financial position.",Susanne Krogh,Hans Christopher Elers Koch,Merck Life Science A/S (former Millipore A/S),KPMG,"In our opinion, the financial statements give a true and fair view of the Company's financial position at 31 December 2014 and of the results of the Company's operations for the financial year 1 January - 31 December 2014 in accordance with the Danish Financial Statements Act.",,,,,,,Copenhagen,2014-12-31,2014-01-01,Copenhagen,,"Management is responsible for the preparation and presentation of financial statements that give a true and fair view in accordance with the Danish Financial Statements Act and for such internal control that Management determines is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.","Pursuant to the Danish Financial Statements Act, we have read the Management's review. We have not performed any further procedures in addition to the audit of the financial statements. On this basis, it is our opinion that the information provided in the Management's review is consistent with the financial statements.","Without modifying our opinion, we draw attention to the fact that the Company does not comply with the requirements of the Danish Bookkeeping Act on preservation of accounting records.",,70707760.0,+45 70 10 56 45,RevisionspÃ¥tegning,,urn:ofk:oid:5447722,indberetninger-20180424,2.5118535,73131510.0,,2018-03-30T13:09:18.582Z,2015-06-04T10:08:14.884Z,regnskab,0.0,,2014-12-31,2014-01-01,X15-AD-15-AL,2015-06-04T10:08:15.276Z,,,,,,,14458000.0,,,,,,,,,,,,,,,,,
73131510,2014-12-31,2014-12-31,c423,,http://regnskaber.virk.dk/01513137/ZG9rdW1lbnRsYWdlcjovLzAzL2ZkLzBlLzhiLzljLzA1YWEtNDVlZi05OWJjLTQxNDg1OTVhNGZiNw.pdf,http://regnskaber.virk.dk/01513137/ZG9rdW1lbnRsYWdlcjovLzAzLzQ4Lzk5LzI4L2I4LzkyZjctNDA2MC04ZTE4LWRjZTk5ZjZhN2YyNQ.xml,Danmark,DK,Copenhagen,2100.0,38.0,Amerika Plads,Danmark,DK,Hellerup,DK-2900,102 E,Strandvejen,2100 KÃ¸benhavn Ã,Amerika Plads 38,To the Shareholder of Merck Life Science A/S (former Millipore A/S),,,,Regnskabsklasse B,The annual report has been prepared in accordance with the Danish Financial Statements Act.,"It is our opinion that the financial statements give a true and fair view of the Company's assets, liabilities and financial position at 31 December 2014 and of the result of the Company's operations  for the year 1 January - 31 December 2014.",,2015-05-29,1982-12-31,2015-05-29,Proposed dividends are recognised as a liability at the date when they are adopted at the annual general meeting (declaration date). The expected dividend payment for the year is disclosed as a separate item under equity.,Staff expenses comprise wages and salaries as well as payroll expenses.,"Interest income and interest expenses comprise interest income and expense, gains and losses on payables and transactions denominated in foreign currencies, amortisation of financial assets and liabilities as well as surcharges and refunds under the on-account tax scheme. etc.",Financial liabilities are measured at amortised cost. Other liabilities are measured at net realisable value.,"Other external expenses comprise expenses incurred for travelling, administration and other external expenses.",Receivables are measured at amortised cost. Provision is made for anticipated losses at net realisable value.,,,,www.millipore.com,25578198.0,73131510.0,25578198.0,The Executive and the Board of Directors have today discussed and approved the annual report of Merck Life Science A/S (former Millipore A/S) for the financial year 1 January - 31 December 2014.,"We have audited the financial statements of Merck Life Science A/S (former Millipore A/S) for the financial year 1 January - 31 December 2014. The financial statements comprise accounting policies, income statement, balance sheet and notes. The financial statements are prepared in accordance with the Danish Financial Statements Act.",Ãrsrapport,"In our opinion, the Management's review includes a fair review of the development in the Company's operations and financial conditions, the result for the year and the financial position.",Susanne Krogh,Hans Christopher Elers Koch,Merck Life Science A/S (former Millipore A/S),KPMG,"In our opinion, the financial statements give a true and fair view of the Company's financial position at 31 December 2014 and of the results of the Company's operations for the financial year 1 January - 31 December 2014 in accordance with the Danish Financial Statements Act.",,,,,,,Copenhagen,2014-12-31,2014-01-01,Copenhagen,,"Management is responsible for the preparation and presentation of financial statements that give a true and fair view in accordance with the Danish Financial Statements Act and for such internal control that Management determines is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.","Pursuant to the Danish Financial Statements Act, we have read the Management's review. We have not performed any further procedures in addition to the audit of the financial statements. On this basis, it is our opinion that the information provided in the Management's review is consistent with the financial statements.","Without modifying our opinion, we draw attention to the fact that the Company does not comply with the requirements of the Danish Bookkeeping Act on preservation of accounting records.",,70707760.0,+45 70 10 56 45,RevisionspÃ¥tegning,,urn:ofk:oid:5447722,indberetninger-20180424,2.5118535,73131510.0,,2018-03-30T13:09:18.582Z,2015-06-04T10:08:14.884Z,regnskab,0.0,,2014-12-31,2014-01-01,X15-AD-15-AL,2015-06-04T10:08:15.276Z,12000.0,,,,,,,,,,,,,,,,,,,,,,,
73131510,2014-12-31,2014-12-31,c425,,http://regnskaber.virk.dk/01513137/ZG9rdW1lbnRsYWdlcjovLzAzL2ZkLzBlLzhiLzljLzA1YWEtNDVlZi05OWJjLTQxNDg1OTVhNGZiNw.pdf,http://regnskaber.virk.dk/01513137/ZG9rdW1lbnRsYWdlcjovLzAzLzQ4Lzk5LzI4L2I4LzkyZjctNDA2MC04ZTE4LWRjZTk5ZjZhN2YyNQ.xml,Danmark,DK,Copenhagen,2100.0,38.0,Amerika Plads,Danmark,DK,Hellerup,DK-2900,102 E,Strandvejen,2100 KÃ¸benhavn Ã,Amerika Plads 38,To the Shareholder of Merck Life Science A/S (former Millipore A/S),,,,Regnskabsklasse B,The annual report has been prepared in accordance with the Danish Financial Statements Act.,"It is our opinion that the financial statements give a true and fair view of the Company's assets, liabilities and financial position at 31 December 2014 and of the result of the Company's operations  for the year 1 January - 31 December 2014.",,2015-05-29,1982-12-31,2015-05-29,Proposed dividends are recognised as a liability at the date when they are adopted at the annual general meeting (declaration date). The expected dividend payment for the year is disclosed as a separate item under equity.,Staff expenses comprise wages and salaries as well as payroll expenses.,"Interest income and interest expenses comprise interest income and expense, gains and losses on payables and transactions denominated in foreign currencies, amortisation of financial assets and liabilities as well as surcharges and refunds under the on-account tax scheme. etc.",Financial liabilities are measured at amortised cost. Other liabilities are measured at net realisable value.,"Other external expenses comprise expenses incurred for travelling, administration and other external expenses.",Receivables are measured at amortised cost. Provision is made for anticipated losses at net realisable value.,,,,www.millipore.com,25578198.0,73131510.0,25578198.0,The Executive and the Board of Directors have today discussed and approved the annual report of Merck Life Science A/S (former Millipore A/S) for the financial year 1 January - 31 December 2014.,"We have audited the financial statements of Merck Life Science A/S (former Millipore A/S) for the financial year 1 January - 31 December 2014. The financial statements comprise accounting policies, income statement, balance sheet and notes. The financial statements are prepared in accordance with the Danish Financial Statements Act.",Ãrsrapport,"In our opinion, the Management's review includes a fair review of the development in the Company's operations and financial conditions, the result for the year and the financial position.",Susanne Krogh,Hans Christopher Elers Koch,Merck Life Science A/S (former Millipore A/S),KPMG,"In our opinion, the financial statements give a true and fair view of the Company's financial position at 31 December 2014 and of the results of the Company's operations for the financial year 1 January - 31 December 2014 in accordance with the Danish Financial Statements Act.",,,,,,,Copenhagen,2014-12-31,2014-01-01,Copenhagen,,"Management is responsible for the preparation and presentation of financial statements that give a true and fair view in accordance with the Danish Financial Statements Act and for such internal control that Management determines is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.","Pursuant to the Danish Financial Statements Act, we have read the Management's review. We have not performed any further procedures in addition to the audit of the financial statements. On this basis, it is our opinion that the information provided in the Management's review is consistent with the financial statements.","Without modifying our opinion, we draw attention to the fact that the Company does not comply with the requirements of the Danish Bookkeeping Act on preservation of accounting records.",,70707760.0,+45 70 10 56 45,RevisionspÃ¥tegning,,urn:ofk:oid:5447722,indberetninger-20180424,2.5118535,73131510.0,,2018-03-30T13:09:18.582Z,2015-06-04T10:08:14.884Z,regnskab,0.0,,2014-12-31,2014-01-01,X15-AD-15-AL,2015-06-04T10:08:15.276Z,7000.0,,,,,,,,,,,,,,,,,,,,,,,
73131510,2014-12-31,2014-12-31,c75,,http://regnskaber.virk.dk/01513137/ZG9rdW1lbnRsYWdlcjovLzAzL2ZkLzBlLzhiLzljLzA1YWEtNDVlZi05OWJjLTQxNDg1OTVhNGZiNw.pdf,http://regnskaber.virk.dk/01513137/ZG9rdW1lbnRsYWdlcjovLzAzLzQ4Lzk5LzI4L2I4LzkyZjctNDA2MC04ZTE4LWRjZTk5ZjZhN2YyNQ.xml,Danmark,DK,Copenhagen,2100.0,38.0,Amerika Plads,Danmark,DK,Hellerup,DK-2900,102 E,Strandvejen,2100 KÃ¸benhavn Ã,Amerika Plads 38,To the Shareholder of Merck Life Science A/S (former Millipore A/S),,,,Regnskabsklasse B,The annual report has been prepared in accordance with the Danish Financial Statements Act.,"It is our opinion that the financial statements give a true and fair view of the Company's assets, liabilities and financial position at 31 December 2014 and of the result of the Company's operations  for the year 1 January - 31 December 2014.",,2015-05-29,1982-12-31,2015-05-29,Proposed dividends are recognised as a liability at the date when they are adopted at the annual general meeting (declaration date). The expected dividend payment for the year is disclosed as a separate item under equity.,Staff expenses comprise wages and salaries as well as payroll expenses.,"Interest income and interest expenses comprise interest income and expense, gains and losses on payables and transactions denominated in foreign currencies, amortisation of financial assets and liabilities as well as surcharges and refunds under the on-account tax scheme. etc.",Financial liabilities are measured at amortised cost. Other liabilities are measured at net realisable value.,"Other external expenses comprise expenses incurred for travelling, administration and other external expenses.",Receivables are measured at amortised cost. Provision is made for anticipated losses at net realisable value.,,,,www.millipore.com,25578198.0,73131510.0,25578198.0,The Executive and the Board of Directors have today discussed and approved the annual report of Merck Life Science A/S (former Millipore A/S) for the financial year 1 January - 31 December 2014.,"We have audited the financial statements of Merck Life Science A/S (former Millipore A/S) for the financial year 1 January - 31 December 2014. The financial statements comprise accounting policies, income statement, balance sheet and notes. The financial statements are prepared in accordance with the Danish Financial Statements Act.",Ãrsrapport,"In our opinion, the Management's review includes a fair review of the development in the Company's operations and financial conditions, the result for the year and the financial position.",Susanne Krogh,Hans Christopher Elers Koch,Merck Life Science A/S (former Millipore A/S),KPMG,"In our opinion, the financial statements give a true and fair view of the Company's financial position at 31 December 2014 and of the results of the Company's operations for the financial year 1 January - 31 December 2014 in accordance with the Danish Financial Statements Act.",,,,,,,Copenhagen,2014-12-31,2014-01-01,Copenhagen,,"Management is responsible for the preparation and presentation of financial statements that give a true and fair view in accordance with the Danish Financial Statements Act and for such internal control that Management determines is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.","Pursuant to the Danish Financial Statements Act, we have read the Management's review. We have not performed any further procedures in addition to the audit of the financial statements. On this basis, it is our opinion that the information provided in the Management's review is consistent with the financial statements.","Without modifying our opinion, we draw attention to the fact that the Company does not comply with the requirements of the Danish Bookkeeping Act on preservation of accounting records.",,70707760.0,+45 70 10 56 45,RevisionspÃ¥tegning,,urn:ofk:oid:5447722,indberetninger-20180424,2.5118535,73131510.0,,2018-03-30T13:09:18.582Z,2015-06-04T10:08:14.884Z,regnskab,0.0,,2014-12-31,2014-01-01,X15-AD-15-AL,2015-06-04T10:08:15.276Z,,27445000.0,2000000.0,27445000.0,19000.0,21000.0,16458000.0,1702000.0,27445000.0,10987000.0,1702000.0,6065000.0,14458000.0,10987000.0,3843000.0,515000.0,25743000.0,10000.0,564000.0,0.0,25693000.0,,,
